The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
Open accessAbstract
Background: Collectively, research on the role of B-cells in the pathogenesis of multiple sclerosis (MS) illustrates how translational medicine has given rise to promising therapeutic approaches for one of the most debilitating chronic neurological diseases in young adults. First described in 1935, the experimental autoimmune/allergic encephalomyelitis model is a key animal model that has provided the foundation for important developments in targeted therapeutics. Summary: While additional B-cell therapies for MS are presently being developed by the pharmaceutical industry, much remains to be understood about the role played by B-cells in MS. The goal of this review is to summarize how B-cells may contribute to MS pathogenesis and thereby provide a basis for understanding why B-cell depletion is so effective in the treatment of this disease. Key Messages: B-cells are key players in the pathogenesis of MS, and their depletion via B-cell-targeted therapy ameliorates disease activity. Clinical Implications: In 2008, data from the first CD20-targeting B-cell depleting therapeutic trials using rituximab in MS were published. Since then, there has been a large body of evidence demonstrating the effectiveness of B-cell depletion mediated via anti-CD20 antibodies. Intense research efforts focusing on the immunopathological relevance of B-cells has gained significant momentum and given rise to a constellation of promising therapeutic agents for this complex B-cell-driven disease, including novel anti-CD20 antibodies, as well as agents targeting CD19 and BAFF-R.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 921
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Cited by
Items 101–127 of 127
The contribution of neuropathology to multiple sclerosis research
Lassmann, H. (2022) · European Journal of Neurology · doi:10.1111/ene.15360 · Cited by 55
Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'Connor, B. P., Arnett, H. A., Fu, Y.-X., Carson, M. J., & Ting, J. P.-Y. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1307-07.2007 · Cited by 51
Zimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
Bruton’s tyrosine kinase inhibition in multiple sclerosis
Schneider, R., & Oh, J. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01229-z · Cited by 47
Inflammatory demyelination alters subcortical visual circuits
Araújo, S. E. S., Mendonça, H. R., Wheeler, N. A., Campello-Costa, P., Jacobs, K. M., Gomes, F. C. A., Fox, M. A., & Fuss, B. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0936-0 · Cited by 43
Strain differences in cuprizone induced demyelination
Yu, Q., Hui, R., Park, J., Huang, Y., Kusnecov, A. W., Dreyfus, C. F., & Zhou, R. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0181-3 · Cited by 46
Zia, S., Hammond, B. P., Zirngibl, M., Sizov, A., Baaklini, C. S., Panda, S. P., Ho, M. F. S., Lee, K. V., Mainali, A., Burr, M. K., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00584-2 · Cited by 40
Spatially resolved gene signatures of white matter lesion progression in multiple sclerosis
Alsema, A. M., Wijering, M. H. C., Miedema, A., Kotah, J. M., Koster, M., Rijnsburger, M., van Weering, H. R. J., de Vries, H. E., Baron, W., Kooistra, S. M., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01765-6 · Cited by 38
Pentón-Rol, G., Lagumersindez-Denis, N., Muzio, L., Bergami, A., Furlan, R., Fernández-Massó, J. R., Nazabal-Galvez, M., Llópiz-Arzuaga, A., Herrera-Rolo, T., Veliz-Rodriguez, T., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9642-9 · Cited by 36
Kratz, A. L., Murphy, S. L., & Braley, T. J. (2017) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2017.07.003 · Cited by 36
Sen, M. K., Almuslehi, M. S. M., Gyengesi, E., Myers, S. J., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2019) · Cells · doi:10.3390/cells8111314 · Cited by 35
Almuslehi, M. S. M., Sen, M. K., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00043 · Cited by 34
Khaw, Y. M., Tierney, A., Cunningham, C., Soto-Díaz, K., Kang, E., Steelman, A. J., & Inoue, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017213118 · Cited by 32
Hofer, L. S., Ramberger, M., Gredler, V., Pescoller, A. S., Rostásy, K., Sospedra, M., Hegen, H., Berger, T., Lutterotti, A., & Reindl, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01188 · Cited by 30
Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis
Solti, I., Kvell, K., Talaber, G., Veto, S., Acs, P., Gallyas, F., Illes, Z., Fekete, K., Zalan, P., Szanto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129217 · Cited by 30
DiSano, K. D., Royce, D. B., Gilli, F., & Pachner, A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01821 · Cited by 30
Guglielmetti, C., Levi, J., Huynh, T. L., Tiret, B., Blecha, J., Tang, R., VanBrocklin, H., & Chaumeil, M. M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.259325 · Cited by 28
Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review
Montañés‐Masias, B., Bort‐Roig, J., Pascual, J. C., Soler, J., & Briones‐Buixassa, L. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13709 · Cited by 27
Viral mouse models used to study multiple sclerosis: past and present
Libbey, J. E., & Fujinami, R. S. (2021) · Archives of Virology · doi:10.1007/s00705-021-04968-5 · Cited by 26
Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface
Costa, M. L., Robinette, M. L., Bugatti, M., Longtine, M. S., Colvin, B. N., Lantelme, E., Vermi, W., Colonna, M., Nelson, D. M., & Cella, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01357 · Cited by 22
Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner
Fazazi, M. R., Doss, P. M. I. A., Pereira, R., Fudge, N., Regmi, A., Joly-Beauparlant, C., Akbar, I., Yeola, A. P., Mailhot, B., Baillargeon, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49259-0 · Cited by 21
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Omura, S., Sato, F., Martinez, N. E., Park, A.-M., Fujita, M., Kennett, N. J., Cvek, U., Minagar, A., Alexander, J. S., & Tsunoda, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00516 · Cited by 20
Yakimov, V., Schweiger, F., Zhan, J., Behrangi, N., Horn, A., Schmitz, C., Hochstrasser, T., & Kipp, M. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01786-4 · Cited by 17
Evaluation strategy to determine reliable demyelination in the cuprizone model
Chrzanowski, U., Schmitz, C., Horn-Bochtler, A., Nack, A., & Kipp, M. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0375-3 · Cited by 16
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue
Gakh, O., Wilkins, J. M., Guo, Y., Popescu, B. F., Weigand, S. D., Kalinowska-Lyszczarz, A., & Lucchinetti, C. F. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01854-4 · Cited by 4
Metadata
- Authors
- von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S.
- Venue
- European Neurology
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 73
- Issue
- 3-4
- Pages
- 238-246
- ISSN
- 0014-3022 (ISSN-L)
- 1421-9913
- OpenAlex
- W2086080135
- Cited by
- 1,463
- References
- 78
- FWCI
- 113.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.